rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2010-11-15
|
pubmed:abstractText |
It is unclear why some adolescents experience substantial bone mineral density (BMD) loss, while others experience a minimal decrease during depot medroxyprogesterone acetate (DMPA) use. We examined biopsychosocial factors in adolescents who experienced ?5% BMD loss from baseline compared with adolescents who experienced <5% BMD loss during DMPA use.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1879-0518
|
pubmed:author |
pubmed-author:BachrachLaura KLK,
pubmed-author:BoneHenryH,
pubmed-author:BrownRobertR,
pubmed-author:BrunerAnnA,
pubmed-author:BurkmanRonaldR,
pubmed-author:CoupeySusanS,
pubmed-author:CromerBarbaraB,
pubmed-author:GoldMelanie AMA,
pubmed-author:HarelZeevZ,
pubmed-author:HertweckPaigeP,
pubmed-author:JohnsonChristine ColeCC,
pubmed-author:MarshallSharonS,
pubmed-author:NelsonAnitaA,
pubmed-author:StagerMargaretM,
pubmed-author:WolterKevinK
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
82
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
503-12
|
pubmed:meshHeading |
pubmed-meshheading:21074012-Adolescent,
pubmed-meshheading:21074012-Alcohol Drinking,
pubmed-meshheading:21074012-Bone Density,
pubmed-meshheading:21074012-Child,
pubmed-meshheading:21074012-Cohort Studies,
pubmed-meshheading:21074012-Contraceptive Agents, Female,
pubmed-meshheading:21074012-Delayed-Action Preparations,
pubmed-meshheading:21074012-Estradiol,
pubmed-meshheading:21074012-Female,
pubmed-meshheading:21074012-Hip Joint,
pubmed-meshheading:21074012-Humans,
pubmed-meshheading:21074012-Lumbar Vertebrae,
pubmed-meshheading:21074012-Medroxyprogesterone Acetate,
pubmed-meshheading:21074012-Prospective Studies,
pubmed-meshheading:21074012-Smoking
|
pubmed:year |
2010
|
pubmed:articleTitle |
Biopsychosocial variables associated with substantial bone mineral density loss during the use of depot medroxyprogesterone acetate in adolescents: adolescents who lost 5% or more from baseline vs. those who lost less than 5%.
|
pubmed:affiliation |
Division of Adolescent Medicine/Hasbro Children's Hospital and Department of Pediatrics/Warren Alpert Medical School of Brown University, Providence, RI 02903, USA. zharel@lifespan.org
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|